Answers are grounded in this paper and cite their sources.
Review reveals multi-tiered prevention strategies for alcohol-associated liver disease, emphasizing integrated addiction care and population-level policies.
Alcohol-associated liver disease (ALD) is the leading cause of morbidity, disease-adjusted life years lost, and mortality worldwide. The significant burden and cost to the healthcare systems from ALD are largely preventable, given that alcohol use is the most important determinant of risk and severity of ALD. In this article, we will review the emerging evidence for public health policies (minimum unit price of alcohol, limiting, or banning alcohol advertising), aiming to reduce the availability of alcohol at the population level (primary prevention), preventing ALD especially advanced form of cirrhosis in at-risk individuals (secondary prevention), and improving liver outcomes and long-term survival in patients with advanced ALD of cirrhosis and/or alcohol-associated hepatitis (tertiary prevention). We will highlight the critical role of clinicians in promoting the public health policies, widespread screening for alcohol use disorder and for ALD, and integrating liver with addiction care for patients with ALD.
No takes yet. Share an insight, caveat, or question.
Burton et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: